aromasin
(exemestane)Pharmacia & Upjohn Company LLC
Usage: AROMASIN is indicated for the adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer after two to three years of tamoxifen therapy, and for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen.